MSN Home  |  My MSN  |  Hotmail
Sign in to Windows Live ID Web Search:   
go to MSNGroups 
Groups Home  |  My Groups  |  Language  |  Help  
 

Important Announcement Important Announcement
The MSN Groups service will close in February 2009. You can move your group to Multiply, MSN’s partner for online groups. Learn More
Friends With RSD/Chronic Pain And Illnesses[email protected] 
  
What's New
  Join Now
  Messages  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  General  
  Games  
  Church Services  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Health Center  
  
  Arthritis  
  
  Back&neck Pain  
  
  Cancer  
  
  Caregiving  
  
  Chronic Ilnness  
  
  Diabetes  
  
  Depression&anxie  
  
  Fibromyalgia  
  
  Health Tips  
  
  Lupus/Autoimmune  
  
  Medication  
  
  Misc. Medical  
  
  MS  
  
  Neurological  
  
  Pain Information  
  
  Rare Diseases  
  
  RSD/CRPS  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Help Center  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Drug Assist Programs  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Dept. Of Aging&Adult Services  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Backgrounds 4 Use  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  Pictures  
  Links  
  ♥.·:*¨¨*:·.♥.·:*:·.♥.·:*¨¨*:·.♥  
  
  
  Tools  
 
Cancer : New Cancer Drug Showing Promise
Choose another message board
 
Prev Discussion  Next Discussion  Send Replies to My Inbox 
Reply
Recommend  Message 1 of 1 in Discussion 
From: MSN Nicknamepray4acure2  (Original Message)Sent: 10/30/2007 4:04 PM
Reported October 30, 2007

New Cancer Drug Showing Promise

(Ivanhoe Newswire) -- A new cancer drug may be able to treat Ewing’s Sarcoma and other sarcoma tumors without all the negative side effects seen with standard treatment.
And early trials suggest the drug may be effective in shrinking the cancers as well.

Ewing’s Sarcoma affects about 300 people in the United States each year, most of them young people. In 20 percent to 30 percent of the patients, the cancer is only diagnosed after it has spread to other parts of the body. Survival among these patients runs around 25 percent to 30 percent.

New findings based on a phase 1 study conducted in 34 adult patients are giving people new hope. The overall purpose of the study was to find out if the treatment could be safely administered. Researchers found tumors stopped growing in nine of the patients after they began receiving the drug. Common side effects of cancer treatment, such as low blood counts, hair loss, nausea and vomiting, and increased infection risk, were either low or nonexistent in the patients.

The investigators believe the drug works by blocking insulin growth factor 1 (IGF-R1), a chemical pathway cancer cells need to thrive. Since this pathway is also present in other cancers, the drug could potentially have a role to play in more common forms of the disease as well, such as cancers of the breast, colon, and prostate.

“This drug and others like it that attack the IGF pathway may provide a new class of drugs to treat a variety of cancers, including breast, prostate, colon, melanoma, myeloma and a variety of sarcomas, which could greatly add to the way that we currently treat these patients,” study author Stephen Leong, M.D., assistant professor of medical oncology at the University of Colorado Cancer Center was quoted as saying.

This article was reported by Ivanhoe.com, which offers Medical Alerts by e-mail every day of the week. To subscribe, click on: http://www.ivanhoe.com/newsalert/.

SOURCE: University of Colorado Cancer Center

[email protected]
Copyright © 2007 Ivanhoe Broadcast News, Inc.
2745 West Fairbanks Avenue
Winter Park, Florida 32789
(407) 740-0789

P.O. Box 865
Orlando, Florida 32802



First  Previous  No Replies  Next  Last 
Notice: Microsoft has no responsibility for the content featured in this group. Click here for more info.
  Try MSN Internet Software for FREE!
    MSN Home  |  My MSN  |  Hotmail  |  Search
Feedback  |  Help  
  ©2005 Microsoft Corporation. All rights reserved.  Legal  Advertise  MSN Privacy